These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 35182428)
1. Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation. Edwards E; Livanos M; Krueger A; Dell A; Haslam SM; Mark Smales C; Bracewell DG Biotechnol Bioeng; 2022 Jun; 119(6):1343-1358. PubMed ID: 35182428 [TBL] [Abstract][Full Text] [Related]
2. Need for a risk-based control strategy for managing glycosylation profile for biosimilar products. Rathore A; Malani H Expert Opin Biol Ther; 2022 Feb; 22(2):123-131. PubMed ID: 34431439 [TBL] [Abstract][Full Text] [Related]
3. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications. Duivelshof BL; Jiskoot W; Beck A; Veuthey JL; Guillarme D; D'Atri V Anal Chim Acta; 2019 Dec; 1089():1-18. PubMed ID: 31627805 [TBL] [Abstract][Full Text] [Related]
4. A rapid method for relative quantification of Segu Z; Stone T; Berdugo C; Roberts A; Doud E; Li Y MAbs; 2020; 12(1):1750794. PubMed ID: 32249667 [TBL] [Abstract][Full Text] [Related]
8. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. Liu L J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915 [TBL] [Abstract][Full Text] [Related]
9. N-glycan Analysis in Molecular Medicine: Innovator and Biosimilar Protein Therapeutics. Borza B; Hajba L; Guttman A Curr Mol Med; 2020; 20(10):828-839. PubMed ID: 33272172 [TBL] [Abstract][Full Text] [Related]
10. Modulation of high mannose levels in N-linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar. Rameez S; Gowtham YK; Nayar G; Mostafa SS Biotechnol Prog; 2021 Sep; 37(5):e3176. PubMed ID: 34021724 [TBL] [Abstract][Full Text] [Related]
11. Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing. Rish AJ; Siddiquee K; Huang Z; Xu J; Anderson CA; Borys MC; Khetan A Biotechnol J; 2023 Jul; 18(7):e2200604. PubMed ID: 37029472 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry. Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058 [TBL] [Abstract][Full Text] [Related]
13. Comparison of glycoprofiles of rituximab versions licensed for sale in India and an analytical approach for quality assessment. Kaur T; Shukla BN; Yadav VK; Kulkarni MJ; Rao A J Proteomics; 2021 Jul; 244():104267. PubMed ID: 34015520 [TBL] [Abstract][Full Text] [Related]
14. Manufacturing plant-made monoclonal antibodies for research or therapeutic applications. Swope K; Morton J; Pogue GP; Hume S; Pauly MH; Shepherd J; Simpson CA; Bratcher B; Whaley KJ; Zeitlin L; Davis KR; Haydon H Methods Enzymol; 2021; 660():239-263. PubMed ID: 34742392 [TBL] [Abstract][Full Text] [Related]
15. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. Ayoub D; Jabs W; Resemann A; Evers W; Evans C; Main L; Baessmann C; Wagner-Rousset E; Suckau D; Beck A MAbs; 2013; 5(5):699-710. PubMed ID: 23924801 [TBL] [Abstract][Full Text] [Related]
16. Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs. Pradhan G; Sneha JM; Sonwane BP; Santhakumari B; Rao A; Kulkarni MJ J Proteomics; 2021 Feb; 232():104053. PubMed ID: 33238212 [TBL] [Abstract][Full Text] [Related]
17. Glycoengineered antibodies: towards the next-generation of immunotherapeutics. Mastrangeli R; Palinsky W; Bierau H Glycobiology; 2019 Mar; 29(3):199-210. PubMed ID: 30289453 [TBL] [Abstract][Full Text] [Related]
18. Glycoproteomics Technologies in Glycobiotechnology. Alagesan K; Hoffmann M; Rapp E; Kolarich D Adv Biochem Eng Biotechnol; 2021; 175():413-434. PubMed ID: 33205259 [TBL] [Abstract][Full Text] [Related]
19. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns. del Val IJ; Kontoravdi C; Nagy JM Biotechnol Prog; 2010; 26(6):1505-27. PubMed ID: 20665659 [TBL] [Abstract][Full Text] [Related]
20. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development. Brady LJ; Velayudhan J; Visone DB; Daugherty KC; Bartron JL; Coon M; Cornwall C; Hinckley PJ; Connell-Crowley L MAbs; 2015; 7(3):562-70. PubMed ID: 25898160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]